Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for Switzerland.
This exact seller page states Switzerland market coverage. It is dated catalog observations, not proof of legal supply, contents, safety, or medical suitability.
Open clean public JSONEach answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for Switzerland. Match the exact category, legal seller identity, and claimed route against the official records on this page.
Resolve the exact identity of Tesamorelin through Check the FDA Purple Book product record from U.S. Food and Drug Administration. Then search Lists of authorized medicinal products from Swissmedic for the destination product record and Guideline on medicines and the Internet from Swissmedic for the seller, establishment, or supply route in Switzerland. A match in one record does not replace the other two checks.
No. A page using the name Tesamorelin, local currency, a domestic delivery claim, or a familiar package image is only a lead. This record resolves seller-labelled 10 mg tesamorelin research listings. EGRIFTA WR is a separate FDA-licensed prescription product with a specific application, 11.6 mg presentation, indication, label, and regulated supply chain. The research listings do not inherit that approval. For Switzerland, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for Switzerland. Match the exact category, legal seller identity, and claimed route against the official records on this page.
Primary identity source: Check the FDA Purple Book product record / U.S. Food and Drug Administration ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Check the FDA Purple Book product record is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Check the FDA Purple Book product record ↗Lists of authorized medicinal products is maintained by Swissmedic. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Lists of authorized medicinal products ↗Guideline on medicines and the Internet is maintained by Swissmedic. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Guideline on medicines and the Internet ↗Swiss medicine authorization and online dispensing are different checks. Swissmedic publishes current authorized-product information, while mail-order dispensing involves legal conditions and cantonal licensing that a foreign seller claim cannot establish.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Use Swissmedic's current lists and product-information platform to match the exact medicine, pack, authorization holder, and status instead of extrapolating from an active-substance name.
Read Swissmedic's internet-medicine guidance and verify the relevant cantonal mail-order licence. A Swiss-looking domain or address is not evidence of that permission.
Import conditions, a customs outcome, and local licensed dispensing are different routes. Record which one an offer claims before comparing price or availability.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.